Literature DB >> 18827965

Serofendic acid protects from iodinated contrast medium and high glucose probably against superoxide production in LLC-PK1 cells.

Osamu Kitamura1, Kazuhide Uemura, Hisayo Kitamura, Hachiro Sugimoto, Akinori Akaike, Takahiko Ono.   

Abstract

BACKGROUND: It is well known that patients with chronic kidney disease, including diabetic nephropathy, often develop cardiovascular diseases. In case of radiographic procedures, reduced renal function may be deteriorated by the use of iodinated contrast medium (CM). This is known as CM-induced nephropathy. In this study, we have focused on the mechanisms of this type of injury in diabetic nephropathy and the preventive effects of serofendic acid.
METHODS: We evaluated the cytotoxicity of CM and high glucose on tubular epithelial cells using an LLC-PK1 cell line, and measured cell viability with an alamarBlue assay. We further evaluated superoxide production levels measured by dihydroethidium. We also examined the protective effects of serofendic acid on cytotoxicity with superoxide production of CM and high glucose.
RESULTS: CM reduced cell numbers in a dose-dependent and time-dependent manner in LLC-PK1 cells. Furthermore, cytotoxicity of CM in diluted concentration was additively influenced by high glucose. CM and high glucose increased superoxide production, which was evaluated by the response to dihydroethidium, and was suppressed by serofendic acid. Cytotoxicity of CM, high glucose, and H(2)O(2) was suppressed by serofendic acid, as well as the suppression by N-acetylcysteine on CM toxicity. Interestingly, the recovery by serofendic acid in H(2)O(2)- and high glucose-induced cellular injury was to the basal level, in contrast with the partial recovery from CM-induced injury. Finally, serofendic acid suppressed CM-induced injury and high glucose-induced apoptosis.
CONCLUSIONS: These results suggest that CM and high glucose induce cytotoxicity and oxidative stress in LLC-PK1 cells and that serofendic acid protects the injury probably from superoxide generation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18827965     DOI: 10.1007/s10157-008-0081-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  34 in total

1.  Structural changes in the renal proximal tubular cells induced by iodinated contrast media.

Authors:  P Tervahartiala; L Kivisaari; R Kivisaari; T Vehmas; I Virtanen
Journal:  Nephron       Date:  1997       Impact factor: 2.847

2.  Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy.

Authors:  R C Thuraisingham; C A Nott; S M Dodd; M M Yaqoob
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

3.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.

Authors:  P Liss; P B Persson; P Hansell; B Lagerqvist
Journal:  Kidney Int       Date:  2006-09-27       Impact factor: 10.612

5.  High glucose initiates calpain-induced necrosis before apoptosis in LLC-PK1 cells.

Authors:  S M Harwood; D A Allen; M J Raftery; M M Yaqoob
Journal:  Kidney Int       Date:  2007-02-07       Impact factor: 10.612

6.  Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress.

Authors:  Istvan Hizoh; Christlieb Haller
Journal:  Invest Radiol       Date:  2002-08       Impact factor: 6.016

7.  Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity.

Authors:  Richard A Zager; Ali C M Johnson; Sherry Y Hanson
Journal:  Kidney Int       Date:  2003-07       Impact factor: 10.612

8.  Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.

Authors:  Sharma Prabhakar; Joel Starnes; Shuping Shi; Betty Lonis; Ruc Tran
Journal:  J Am Soc Nephrol       Date:  2007-10-10       Impact factor: 10.121

Review 9.  Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.

Authors:  Kunihiro Yamagata; Kunitoshi Iseki; Kousaku Nitta; Hirokazu Imai; Yasuhiko Iino; Seiichi Matsuo; Hirofumi Makino; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

10.  Modulation of radiation-induced chromosome aberrations by DMSO, an OH radical scavenger. 1: Dose-response studies in human lymphocytes exposed to 220 kV X-rays.

Authors:  L G Littlefield; E E Joiner; S P Colyer; A M Sayer; E L Frome
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1988-06
View more
  4 in total

1.  Assessment of an advanced virtual monoenergetic reconstruction technique in cerebral and cervical angiography with third-generation dual-source CT: Feasibility of using low-concentration contrast medium.

Authors:  Lu Zhao; Fengtan Li; Zewei Zhang; Zhang Zhang; Yingjian Jiang; Xinyu Wang; Jun Gu; Dong Li
Journal:  Eur Radiol       Date:  2018-04-13       Impact factor: 5.315

2.  Albumin and glycated albumin activate KIM-1 release in tubular epithelial cells through distinct kinetics and mechanisms.

Authors:  Ai Ing Lim; Loretta Y Y Chan; Sydney C W Tang; Kar Neng Lai; Joseph C K Leung
Journal:  Inflamm Res       Date:  2014-07-26       Impact factor: 4.575

3.  The Ameliorative Role of Acacia senegal Gum against the Oxidative Stress and Genotoxicity Induced by the Radiographic Contrast Medium (Ioxitalamate) in Albino Rats.

Authors:  Islam El-Garawani; Sobhy Hassab El-Nabi; Ahmed El Kattan; Azza Sallam; Sabha Elballat; Shaimaa Abou-Ghanima; Islam H El Azab; Hesham R El-Seedi; Shaden A M Khalifa; Sawsan El-Shamy
Journal:  Antioxidants (Basel)       Date:  2021-02-02

4.  Hu-Lu-Ba-Wan Attenuates Diabetic Nephropathy in Type 2 Diabetic Rats through PKC- α /NADPH Oxidase Signaling Pathway.

Authors:  Lishan Zhou; Hui Dong; Yi Huang; Lijun Xu; Xin Zou; Kaifu Wang; Guang Chen; Fuer Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-25       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.